Cerdelga was evaluated in clinical studies involving 199 people with type 1 Gaucher disease. The most common side effects were fatigue, headache, nausea, diarrhea, and pain of the back, arms and ...

Sanofi ( SNY) announced that the FDA has approved Cerdelga for the treatment of Gaucher disease type 1.However, the drug is not indicated for adults suffering from Gaucher disease type 1 who ...